nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—Malaise—Methylprednisolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Raltegravir—Vertigo—Triamcinolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Raltegravir—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00145	0.00145	CcSEcCtD
Raltegravir—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00144	0.00144	CcSEcCtD
Raltegravir—Neutropenia—Methotrexate—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Raltegravir—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Raltegravir—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Raltegravir—Cough—Triamcinolone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Raltegravir—Hypertension—Triamcinolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Raltegravir—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00138	0.00138	CcSEcCtD
Raltegravir—Myalgia—Triamcinolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Raltegravir—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Raltegravir—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Raltegravir—Eye disorder—Prednisone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Raltegravir—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00137	0.00137	CcSEcCtD
Raltegravir—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Raltegravir—Infestation—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Raltegravir—Depression—Methotrexate—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Raltegravir—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Raltegravir—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Raltegravir—Discomfort—Triamcinolone—ankylosing spondylitis	0.00136	0.00136	CcSEcCtD
Raltegravir—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Raltegravir—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Raltegravir—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Raltegravir—Renal failure—Methotrexate—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Raltegravir—Angiopathy—Prednisone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Raltegravir—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Raltegravir—Immune system disorder—Prednisone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Raltegravir—Malaise—Betamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Raltegravir—Malaise—Dexamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Raltegravir—Vertigo—Betamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Raltegravir—Vertigo—Dexamethasone—ankylosing spondylitis	0.00132	0.00132	CcSEcCtD
Raltegravir—Infection—Triamcinolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Raltegravir—Infection—Methylprednisolone—ankylosing spondylitis	0.00131	0.00131	CcSEcCtD
Raltegravir—Haematuria—Methotrexate—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Raltegravir—Insomnia—Prednisolone—ankylosing spondylitis	0.0013	0.0013	CcSEcCtD
Raltegravir—Alopecia—Prednisone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Raltegravir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Raltegravir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Raltegravir—Epistaxis—Methotrexate—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Raltegravir—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00129	0.00129	CcSEcCtD
Raltegravir—Mental disorder—Prednisone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Raltegravir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Raltegravir—Erythema—Prednisone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Raltegravir—Malnutrition—Prednisone—ankylosing spondylitis	0.00128	0.00128	CcSEcCtD
Raltegravir—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Raltegravir—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00127	0.00127	CcSEcCtD
Raltegravir—Hypertension—Dexamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Raltegravir—Hypertension—Betamethasone—ankylosing spondylitis	0.00126	0.00126	CcSEcCtD
Raltegravir—Myalgia—Dexamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Raltegravir—Myalgia—Betamethasone—ankylosing spondylitis	0.00125	0.00125	CcSEcCtD
Raltegravir—Anxiety—Dexamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Raltegravir—Anxiety—Betamethasone—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Raltegravir—Discomfort—Dexamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Raltegravir—Discomfort—Betamethasone—ankylosing spondylitis	0.00123	0.00123	CcSEcCtD
Raltegravir—Pain—Prednisolone—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Raltegravir—Hepatitis—Methotrexate—ankylosing spondylitis	0.00122	0.00122	CcSEcCtD
Raltegravir—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00121	0.00121	CcSEcCtD
Raltegravir—Urethral disorder—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Raltegravir—Insomnia—Triamcinolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Raltegravir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Raltegravir—Infection—Betamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Raltegravir—Infection—Dexamethasone—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Raltegravir—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Raltegravir—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Raltegravir—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Raltegravir—Visual impairment—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Raltegravir—Anaemia—Prednisone—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Raltegravir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Raltegravir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Raltegravir—Agitation—Prednisone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Raltegravir—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Raltegravir—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00117	0.00117	CcSEcCtD
Raltegravir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Raltegravir—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Raltegravir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Raltegravir—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Raltegravir—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00116	0.00116	CcSEcCtD
Raltegravir—Malaise—Prednisone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Raltegravir—Vertigo—Prednisone—ankylosing spondylitis	0.00115	0.00115	CcSEcCtD
Raltegravir—Eye disorder—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Raltegravir—Tinnitus—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Raltegravir—Urticaria—Prednisolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Raltegravir—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Raltegravir—Fatigue—Triamcinolone—ankylosing spondylitis	0.00114	0.00114	CcSEcCtD
Raltegravir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Raltegravir—Pain—Triamcinolone—ankylosing spondylitis	0.00113	0.00113	CcSEcCtD
Raltegravir—Angiopathy—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Raltegravir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00111	0.00111	CcSEcCtD
Raltegravir—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Raltegravir—Hypertension—Prednisone—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Raltegravir—Chills—Methotrexate—ankylosing spondylitis	0.0011	0.0011	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Raltegravir—Myalgia—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Raltegravir—Arthralgia—Prednisone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Raltegravir—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00109	0.00109	CcSEcCtD
Raltegravir—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Raltegravir—Anxiety—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Raltegravir—Alopecia—Methotrexate—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Raltegravir—Insomnia—Dexamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Raltegravir—Insomnia—Betamethasone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00108	0.00108	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Raltegravir—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Raltegravir—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Raltegravir—Discomfort—Prednisone—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Raltegravir—Mental disorder—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Raltegravir—Erythema—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Raltegravir—Malnutrition—Methotrexate—ankylosing spondylitis	0.00107	0.00107	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00106	0.00106	CcSEcCtD
Raltegravir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Raltegravir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Raltegravir—Urticaria—Triamcinolone—ankylosing spondylitis	0.00105	0.00105	CcSEcCtD
Raltegravir—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Raltegravir—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Raltegravir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Raltegravir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Raltegravir—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Raltegravir—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00104	0.00104	CcSEcCtD
Raltegravir—Infection—Prednisone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Raltegravir—Back pain—Methotrexate—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Raltegravir—Fatigue—Dexamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Raltegravir—Fatigue—Betamethasone—ankylosing spondylitis	0.00103	0.00103	CcSEcCtD
Raltegravir—Pain—Betamethasone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Raltegravir—Pain—Dexamethasone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Raltegravir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00102	0.00102	CcSEcCtD
Raltegravir—Skin disorder—Prednisone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Raltegravir—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00101	0.00101	CcSEcCtD
Raltegravir—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000989	0.000989	CcSEcCtD
Raltegravir—Anaemia—Methotrexate—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Raltegravir—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Raltegravir—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000985	0.000985	CcSEcCtD
Raltegravir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000977	0.000977	CcSEcCtD
Raltegravir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000977	0.000977	CcSEcCtD
Raltegravir—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00097	0.00097	CcSEcCtD
Raltegravir—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000968	0.000968	CcSEcCtD
Raltegravir—Malaise—Methotrexate—ankylosing spondylitis	0.000961	0.000961	CcSEcCtD
Raltegravir—Vertigo—Methotrexate—ankylosing spondylitis	0.000958	0.000958	CcSEcCtD
Raltegravir—Urticaria—Betamethasone—ankylosing spondylitis	0.000949	0.000949	CcSEcCtD
Raltegravir—Urticaria—Dexamethasone—ankylosing spondylitis	0.000949	0.000949	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000948	0.000948	CcSEcCtD
Raltegravir—Dizziness—Prednisolone—ankylosing spondylitis	0.000947	0.000947	CcSEcCtD
Raltegravir—Asthenia—Triamcinolone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Raltegravir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Raltegravir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Raltegravir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Raltegravir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000945	0.000945	CcSEcCtD
Raltegravir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000943	0.000943	CcSEcCtD
Raltegravir—Insomnia—Prednisone—ankylosing spondylitis	0.000941	0.000941	CcSEcCtD
Raltegravir—Paraesthesia—Prednisone—ankylosing spondylitis	0.000935	0.000935	CcSEcCtD
Raltegravir—Pruritus—Triamcinolone—ankylosing spondylitis	0.000932	0.000932	CcSEcCtD
Raltegravir—Cough—Methotrexate—ankylosing spondylitis	0.00093	0.00093	CcSEcCtD
Raltegravir—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00093	0.00093	CcSEcCtD
Raltegravir—Dyspepsia—Prednisone—ankylosing spondylitis	0.000916	0.000916	CcSEcCtD
Raltegravir—Chest pain—Methotrexate—ankylosing spondylitis	0.000907	0.000907	CcSEcCtD
Raltegravir—Myalgia—Methotrexate—ankylosing spondylitis	0.000907	0.000907	CcSEcCtD
Raltegravir—Arthralgia—Methotrexate—ankylosing spondylitis	0.000907	0.000907	CcSEcCtD
Raltegravir—Decreased appetite—Prednisone—ankylosing spondylitis	0.000905	0.000905	CcSEcCtD
Raltegravir—Rash—Prednisolone—ankylosing spondylitis	0.000903	0.000903	CcSEcCtD
Raltegravir—Dermatitis—Prednisolone—ankylosing spondylitis	0.000902	0.000902	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000901	0.000901	CcSEcCtD
Raltegravir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000899	0.000899	CcSEcCtD
Raltegravir—Fatigue—Prednisone—ankylosing spondylitis	0.000897	0.000897	CcSEcCtD
Raltegravir—Headache—Prednisolone—ankylosing spondylitis	0.000897	0.000897	CcSEcCtD
Raltegravir—Discomfort—Methotrexate—ankylosing spondylitis	0.000896	0.000896	CcSEcCtD
Raltegravir—Constipation—Prednisone—ankylosing spondylitis	0.00089	0.00089	CcSEcCtD
Raltegravir—Confusional state—Methotrexate—ankylosing spondylitis	0.000877	0.000877	CcSEcCtD
Raltegravir—Dizziness—Triamcinolone—ankylosing spondylitis	0.000871	0.000871	CcSEcCtD
Raltegravir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000869	0.000869	CcSEcCtD
Raltegravir—Infection—Methotrexate—ankylosing spondylitis	0.000864	0.000864	CcSEcCtD
Raltegravir—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000858	0.000858	CcSEcCtD
Raltegravir—Asthenia—Dexamethasone—ankylosing spondylitis	0.000857	0.000857	CcSEcCtD
Raltegravir—Asthenia—Betamethasone—ankylosing spondylitis	0.000857	0.000857	CcSEcCtD
Raltegravir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000853	0.000853	CcSEcCtD
Raltegravir—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000852	0.000852	CcSEcCtD
Raltegravir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000851	0.000851	CcSEcCtD
Raltegravir—Nausea—Prednisolone—ankylosing spondylitis	0.000851	0.000851	CcSEcCtD
Raltegravir—Pruritus—Dexamethasone—ankylosing spondylitis	0.000846	0.000846	CcSEcCtD
Raltegravir—Pruritus—Betamethasone—ankylosing spondylitis	0.000846	0.000846	CcSEcCtD
Raltegravir—Skin disorder—Methotrexate—ankylosing spondylitis	0.000845	0.000845	CcSEcCtD
Raltegravir—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000841	0.000841	CcSEcCtD
Raltegravir—Vomiting—Triamcinolone—ankylosing spondylitis	0.000837	0.000837	CcSEcCtD
Raltegravir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000836	0.000836	CcSEcCtD
Raltegravir—Rash—Triamcinolone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Raltegravir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00083	0.00083	CcSEcCtD
Raltegravir—Rash—Methylprednisolone—ankylosing spondylitis	0.000829	0.000829	CcSEcCtD
Raltegravir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000828	0.000828	CcSEcCtD
Raltegravir—Urticaria—Prednisone—ankylosing spondylitis	0.000827	0.000827	CcSEcCtD
Raltegravir—Headache—Triamcinolone—ankylosing spondylitis	0.000825	0.000825	CcSEcCtD
Raltegravir—Headache—Methylprednisolone—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Raltegravir—Body temperature increased—Prednisone—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Raltegravir—Abdominal pain—Prednisone—ankylosing spondylitis	0.000823	0.000823	CcSEcCtD
Raltegravir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000818	0.000818	CcSEcCtD
Raltegravir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000818	0.000818	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000792	0.000792	CcSEcCtD
Raltegravir—Dizziness—Betamethasone—ankylosing spondylitis	0.00079	0.00079	CcSEcCtD
Raltegravir—Dizziness—Dexamethasone—ankylosing spondylitis	0.00079	0.00079	CcSEcCtD
Raltegravir—Insomnia—Methotrexate—ankylosing spondylitis	0.000787	0.000787	CcSEcCtD
Raltegravir—Nausea—Triamcinolone—ankylosing spondylitis	0.000782	0.000782	CcSEcCtD
Raltegravir—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000781	0.000781	CcSEcCtD
Raltegravir—Nausea—Methylprednisolone—ankylosing spondylitis	0.000781	0.000781	CcSEcCtD
Raltegravir—Somnolence—Methotrexate—ankylosing spondylitis	0.000773	0.000773	CcSEcCtD
Raltegravir—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000767	0.000767	CcSEcCtD
Raltegravir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000766	0.000766	CcSEcCtD
Raltegravir—Vomiting—Betamethasone—ankylosing spondylitis	0.00076	0.00076	CcSEcCtD
Raltegravir—Vomiting—Dexamethasone—ankylosing spondylitis	0.00076	0.00076	CcSEcCtD
Raltegravir—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000756	0.000756	CcSEcCtD
Raltegravir—Rash—Betamethasone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Raltegravir—Rash—Dexamethasone—ankylosing spondylitis	0.000754	0.000754	CcSEcCtD
Raltegravir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000753	0.000753	CcSEcCtD
Raltegravir—Dermatitis—Betamethasone—ankylosing spondylitis	0.000753	0.000753	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000751	0.000751	CcSEcCtD
Raltegravir—Fatigue—Methotrexate—ankylosing spondylitis	0.00075	0.00075	CcSEcCtD
Raltegravir—Headache—Dexamethasone—ankylosing spondylitis	0.000749	0.000749	CcSEcCtD
Raltegravir—Headache—Betamethasone—ankylosing spondylitis	0.000749	0.000749	CcSEcCtD
Raltegravir—Asthenia—Prednisone—ankylosing spondylitis	0.000747	0.000747	CcSEcCtD
Raltegravir—Pain—Methotrexate—ankylosing spondylitis	0.000744	0.000744	CcSEcCtD
Raltegravir—Pruritus—Prednisone—ankylosing spondylitis	0.000736	0.000736	CcSEcCtD
Raltegravir—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000717	0.000717	CcSEcCtD
Raltegravir—Diarrhoea—Prednisone—ankylosing spondylitis	0.000712	0.000712	CcSEcCtD
Raltegravir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000711	0.000711	CcSEcCtD
Raltegravir—Nausea—Betamethasone—ankylosing spondylitis	0.00071	0.00071	CcSEcCtD
Raltegravir—Nausea—Dexamethasone—ankylosing spondylitis	0.00071	0.00071	CcSEcCtD
Raltegravir—Urticaria—Methotrexate—ankylosing spondylitis	0.000691	0.000691	CcSEcCtD
Raltegravir—Dizziness—Prednisone—ankylosing spondylitis	0.000688	0.000688	CcSEcCtD
Raltegravir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000688	0.000688	CcSEcCtD
Raltegravir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000688	0.000688	CcSEcCtD
Raltegravir—Vomiting—Prednisone—ankylosing spondylitis	0.000662	0.000662	CcSEcCtD
Raltegravir—Rash—Prednisone—ankylosing spondylitis	0.000656	0.000656	CcSEcCtD
Raltegravir—Dermatitis—Prednisone—ankylosing spondylitis	0.000656	0.000656	CcSEcCtD
Raltegravir—Headache—Prednisone—ankylosing spondylitis	0.000652	0.000652	CcSEcCtD
Raltegravir—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000641	0.000641	CcSEcCtD
Raltegravir—Asthenia—Methotrexate—ankylosing spondylitis	0.000624	0.000624	CcSEcCtD
Raltegravir—Nausea—Prednisone—ankylosing spondylitis	0.000618	0.000618	CcSEcCtD
Raltegravir—Pruritus—Methotrexate—ankylosing spondylitis	0.000615	0.000615	CcSEcCtD
Raltegravir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000595	0.000595	CcSEcCtD
Raltegravir—Dizziness—Methotrexate—ankylosing spondylitis	0.000575	0.000575	CcSEcCtD
Raltegravir—Vomiting—Methotrexate—ankylosing spondylitis	0.000553	0.000553	CcSEcCtD
Raltegravir—Rash—Methotrexate—ankylosing spondylitis	0.000548	0.000548	CcSEcCtD
Raltegravir—Dermatitis—Methotrexate—ankylosing spondylitis	0.000548	0.000548	CcSEcCtD
Raltegravir—Headache—Methotrexate—ankylosing spondylitis	0.000545	0.000545	CcSEcCtD
Raltegravir—Nausea—Methotrexate—ankylosing spondylitis	0.000517	0.000517	CcSEcCtD
